Terug
47
Dagbereik
€ 9,69
€ 10,20
52-Weeksbereik
€ 1,78
€ 11,49
Volume
2.001.523
50D / 200D Gem.
€ 8,91
/
€ 6,19
Vorige Slotkoers
€ 9,91
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -6,4 | 0,4 |
| P/B | 3,1 | 2,9 |
| ROE % | -41,1 | 3,8 |
| Net Margin % | -1800,6 | 3,9 |
| Rev Growth 5Y % | 50,1 | 10,0 |
| D/E | 0,1 | 0,2 |
Belangrijkste Punten
Revenue grew 50,05% annually over 5 years — strong growth
Debt/Equity of 0,06 — conservative balance sheet
Negative free cash flow of -235,87M
PEG of 0,17 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3,39%
Capital efficient — spends only 2,67% of revenue on capex
Groei
Revenue Growth (5Y)
50,05%
Revenue (1Y)53,44%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-41,12%
ROIC-37,87%
Net Margin-1800,58%
Op. Margin-1971,59%
Veiligheid
Debt / Equity
0,06
Current Ratio22,61
Interest Coverage0,00
Waardering
P/E Ratio
-6,35
P/B Ratio3,10
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 53,44% | Revenue Growth (3Y) | -22,47% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 50,05% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 15,36M | Net Income (TTM) | -276,48M |
| ROE | -41,12% | ROA | -44,50% |
| Gross Margin | 76,83% | Operating Margin | -1971,59% |
| Net Margin | -1800,58% | Free Cash Flow (TTM) | -235,87M |
| ROIC | -37,87% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,06 | Current Ratio | 22,61 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -6,35 | P/B Ratio | 3,10 |
| P/S Ratio | 114,30 | PEG Ratio | 0,17 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,76B | Enterprise Value | 1,70B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 15,36M | 10,01M | 25,55M | 1,38M | 3,03M |
| Net Income | -276,48M | -337,71M | -341,97M | -290,51M | -363,87M |
| EPS (Diluted) | -1,61 | -2,36 | -2,79 | -2,59 | -3,82 |
| Gross Profit | 11,80M | 10,01M | 25,55M | 1,38M | 3,03M |
| Operating Income | -302,74M | -372,47M | -373,00M | -299,28M | -364,70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 621,33M | 871,30M | 843,98M | 1,10B | 1,01B |
| Total Liabilities | 54,27M | 93,50M | 91,98M | 149,55M | 110,64M |
| Shareholders' Equity | 567,06M | 777,79M | 752,00M | 950,22M | 897,81M |
| Total Debt | 32,46M | 48,50M | 53,47M | 57,74M | 22,90M |
| Cash & Equivalents | 84,02M | 124,29M | 143,74M | 998,92M | 280,12M |
| Current Assets | 578,28M | 809,20M | 770,10M | 1,02B | 976,24M |
| Current Liabilities | 25,58M | 50,73M | 30,27M | 63,71M | 24,32M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#68 of 146
Recente Activiteit
Ingestapt
Full Throttle
Mar 24, 2026